Found: 7
Select item for more details and to access through your institution.
Translational findings for odronextamab: From preclinical research to a first‐in‐human study in patients with CD20+ B‐cell malignancies.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 4, p. 954, doi. 10.1111/cts.13212
- By:
- Publication type:
- Article
Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93842-0
- By:
- Publication type:
- Article
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 549, p. 1, doi. 10.1126/scitranslmed.aba2325
- By:
- Publication type:
- Article
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 525, p. 1, doi. 10.1126/scitranslmed.aaw7888
- By:
- Publication type:
- Article
A Mucin 16 bispecific T cell–engaging antibody for the treatment of ovarian cancer.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 497, p. 1, doi. 10.1126/scitranslmed.aau7534
- By:
- Publication type:
- Article
A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys.
- Published in:
- Scientific Reports, 2015, p. 17943, doi. 10.1038/srep17943
- By:
- Publication type:
- Article
High Affinity Antigen Recognition of the Dual Specific Variants of Herceptin Is Entropy-Driven in Spite of Structural Plasticity.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0017887
- By:
- Publication type:
- Article